Of note, patients with AD show both reduced glycogen load (Bass et al., 2015) and increased glycogen synthesis‐regulating GSK3beta (Reddy, 2013) which is shown to lower production of glycogen (Bass et al., 2015; Beurel et al., 2015). Here, GSK3B is linked to Alzheimer disease.